Insulin Delivery Devices Market Size in 2023 To 2029 | Embecta Corp. (Formely Becton, Dickinson and Company Diabetes Care Business (US), Ypsomed Holding AG (Switzerland), Tandem Diabetes Care (US), Insulet Corporation (US), Biocon Limited (India), Novo No

𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐢𝐧𝐬𝐮𝐥𝐢𝐧 𝐝𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 𝟒𝟔.𝟐 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟖 𝐟𝐫𝐨𝐦 𝐔𝐒𝐃 𝟑𝟎.𝟖 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑, 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟖.𝟓% 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝.

🔥 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 + 𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐓𝐎𝐂 ➡️ https://www.reportsnreports.com/contacts/requestsample.aspx?name=972929

The prominent players operating in the global insulin delivery devices market are Embecta Corp. (Formely Becton, Dickinson and Company Diabetes Care Business (US), Ypsomed Holding AG (Switzerland), Tandem Diabetes Care (US), Insulet Corporation (US), Biocon Limited (India), Novo Nordisk A/S (Denmark), Medtronic (Ireland), Sanofi (France), Eli Lilly and Company (US), Roche Diabetes Care (Switzerland), Owen Mumford (England), Mrdtrum Technologies Inc. (China), Terumo Corporation (Japan), Wockhardt (India), Cerur Corporation (Switzerland), EoFlow CO., Ltd. (South Korea), Hindustan Syringes & Medical Devices Ltd (India), Sooil Developments CO., Ltd (Korea), Sungshim Medical Co., Ltd. (South Korea), Vicentra B.V. (Netherland), Debiotech SA (Switzerland), Jiangsu Delfu Medical Device Co., Ltd (China), Haselmeier (Germany), Mannkind Corporation (US), HTL-Sterfa S.A. (Poland).

Insulin pumps segment is projected to grow at the highest CAGR during the forecast period

By type, the global insulin delivery devices market is segmented into insulin pens, insulin pumps, insulin pen needles, insulin syringes and other insulin delivery devices which includes, transdermal insulin patch, insulin jet injectors, insulin inhalers. The insulin pump segment is further sub-segmented into tethered insulin pumps and tubeless insulin pumps. As newer and more refined technology has now revolutionized insulin pumps in terms of their quality of care, and ease of use resulting in improved glycemic control, in addition favourable reimbursement in developed countries is contributing towards the adoption of these devices as a result this segment is projected to have the highest CAGR in the forecast period.

Patients/Homecare end user segment is projected to grow at the highest CAGR during the forecast period

By end users, the insulin delivery devices market is segmented into patients/ homecare and hospitals & clinics. The patients/home care segment is expected to grow at the highest CAGR during the forecast period. This is primarily attributed to the rising patient acceptance of home care as a result of growing awareness of diabetes care devices, increasing diabetic healthcare expenditure and favourable reimbursements.

By region, North America is projected to account for the largest share of the insulin delivery devices market

Based on region, the insulin delivery devices market is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America dominated the insulin delivery devices market in 2022. The growth of connected diabetes management devices, the rising diabetic population, demand for technologically advanced products, government initiatives, and increasing awareness of self-diabetes management in the region are the main factors driving North America to dominate the insulin delivery devices market.

➡️ 𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐅𝐨𝐫 𝐌𝐨𝐫𝐞 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 @ https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=972929

This report provides insights into the following pointers:

Analysis of key drivers (growing prevalence of diabetic population, technological advancements in insulin delivery devices, government support and favourable reimbursement schemes to favour market growth), restraints (high cost and lack of reimbursement in developing countries, needle anxiety in patients to affect the growth of the pen needles and syringes market, oral insulin as an alternative drug delivery method), opportunities (increasing research and development activities and strategic partnerships, advances in syringe and technology) and challenges (Needle stick injuries and misuse of injection pens)

Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new product launches in the global insulin delivery devices market
Market Development: Comprehensive information on the lucrative emerging markets by type, end user, and region.
Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global insulin delivery devices market.
Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global insulin delivery devices market. This report also helps stakeholders understand the pulse of the molecular quality controls market and provides them information on key market drivers, restraints, challenges, and opportunities.

This release was published on openPR.